The association between adiponectin (+45T/G) and adiponectin receptor-2 (+795G/A) single nucleotide polymorphisms with cirrhosis in Iranian population

Molecular Biology Reports

Volumn 39, Issue 3, 2012, Pages 3219-3223

  Namvaran, Fatemeh ^a,b,c   Rahimi Moghaddam, Parvaneh ^a,c   Azarpira, Negar ^b   Nikeghbalian, Saman ^d  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adiponectin gene; Adiponectin receptor 2 gene; Cirrhosis; Iranian population; Polymorphisms

Indexed keywords

ADENINE; ADIPONECTIN; ADIPONECTIN RECEPTOR 2; GUANIDINE; THYMIDINE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRANIAN; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 85027919784     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1089-3     Document Type: Article

References (42)

1. Berg AH, Combs TP, DU X, Brownlee M et al (2001) The adipocyte-secreted protein ACRP30 enhances hepatic insulin action. Nat Med 7:947
2. Chandran M, Phillip SA, Ciaraldi T et al (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care 26:2442
3. Goldfine AB, Kahn CR (2003) Adiponectin: linking the fat cell to insulin sensitivity. Lancet 362:1431
4. Funahashi T, Nakamura T, Shimomura I (1999) Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 38:202
5. Yokota T, Oritani K, Takahashi I et al (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophage. Blood 96:1723
6. Anita Y, Kihara S, Ouchi N et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79
7. Hu E, Liang P, Spiegelman BM (1996) AdipoQ is a novel adipocyte specific gene dysregulated in obesity. J Biol Chem 271: 10697
8. Hota K, Funahashi T, Bodkin NL et al (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126
9. Bajaj M, Suraamornkul S, Piper P et al (2004) Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 89:200
10. Al-Daghri NM, Al-Attas OS, Alokail MS et al (2011) Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes. Mol Biol Rep 38(6):3703-3708
11. Liu F, He Z, Sh Deng et al (2011) Association of adiponectin gene polymorphisms with the risk of ischemic stroke in a Chinese Han population. Mol Biol Rep 38:1983-1988
12. Combs TP, Bger AH, Obici S et al (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875
13. Yamauchi T, Kamon J, Waki H et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941
14. Danforth E (2000) Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 26:13
15. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221
16. TietgeI UJ, Boker KH, Manns MP et al (2004) Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab 287:E82
17. Xu A, Wang Y, Keshaw H et al (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91
18. Hui CK, Zhang HY, Lee NP et al (2007) Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. J Hepatol 47:191
19. Kaser S, Moschen A, Kaser A et al (2005) Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis. J Intern Med 258:274
20. Hotta K, Funahashi T, Aritay et al (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595
21. Ouchi N, Kihara S, Aritay et al (1999) Novel modulator for endothelial adhesion molecules: adipocytes-derived plasma protein adiponectin. Circulation 100:2473
22. Petride AS, Defronzo RA (1989) Glucose and insulin metabolism in cirrhosis. J Hepatol 8:107
23. Kaser S, Foger B, Waldenbrger P et al (2000) Transjugular intrahepatic portosystemic shunt (TIPS) augments hyperinsulinemia in patients with cirrhosis. J Hepatol 33:902
24. Petride AS (1994) Liver disease and diabetes mellitus. Diabetes Rev 2:2-18
25. Pagano C, Soardo G, Esposito W et al (2005) Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol 152:113
26. Tilg H, Wilmer A, Vogel W et al (1992) Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264
27. Ludwiczek O, Kaser A, Novick D et al (2002) Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease. J Clin Immunol 22:331
28. Masaki T, Chiba S, Tatsukawa H et al (2004) Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology 40:177
29. Man K, Ng KT, Xu A et al (2010) Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and down regulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling. Clin Cancer Res 16:967
30. Kamada Y, Tamura S, Kiso S et al (2003) Enhanced carbon tetrachloride induced liver fibrosis in mice lacking adiponectin. Gastroenterology 125:1796
31. Kara K, Boutin P, Mori Y et al (2002) Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536
32. Pollin T, Tanner I, O'connell R et al (2005) Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. Diabetes 24:268
33. Vaxillair M, Dechaume A, Vasseur V et al (2006) Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms for type 2 diabetes in the Caucasian population. Diabetes 55:856
34. Damcott CM, Ott SH, Pollin T et al (2005) Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the old order Amish. Diabetes 54:2245
35. Li LL, Kang XL, Ran XJ et al (2007) Associations between 45T/ G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. Clin Exp Pharmacol Physiol 34: 1287-1290
36. Kalnina I, Latkovskis G, Nkitina L et al (2009) Analysis of polymorphisms at the adiponectin gene locus in association with type 2 diabetes, body mass index and cardiovascular traits in Latvian population. Proc Lav Acad Sci 63:174
37. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, Kawamoto S, Kubota N, Kubota T et al (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13:332-339
38. Debard C, Laville M, Berbe V, Loizon E, Guillet C, Morio-Liondore B, Boirie Y, Vidal H (2004) Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of type 2 diabetic patients. Diabetologia 47:917-925
39. Potapov VA, Chistiakov DA, Dubinina A, Shamkhalova MS, Shestakova MV, Nosikov VV (2008) Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes. Rev Diabet Stud 5:28-37
40. Xita N, Georgion I, Chatzikyriakido A et al (2005) Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem 51:41
41. Wang ZL, Xia B, Shrestha U, Jiang L, Ma CW, Chen Q, Chen H, Hu ZG (2008) Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population. J Endocrinol Invest 31(12): 1086-1091
42. Musso G, Gambino R, De Michieli F, Durazzo M, Pagano G, Cassader M (2008) Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: possible pathogenetic role in NASH. Hepatology 47:1167-1177